The First Pharmaceutical Packaging Company to have UK Distribution Site Certificate

Nov. 9, 2015 - PRLog -- ISO 15378 is specifically for suppliers of pharmaceutical primary packaging. Origin’s Pharmaceutical Packaging, Distribution and Innovation Centre and team was subjected to a comprehensive auditing process involving a multiple day inspection. This included evaluating GMP trained operators, the supplier approval process, change controls, quality assessments and quality release. Origin have invested substantially to achieve this pharmaceutical recognised standard, and now identifies with GMP principles, specifies requirements for a quality managed supply chain applicable to primary packaging materials for medicinal products.

This is a key achievement for Origin as it is consistent with the commitment to ‘bring healing home’ and underpins our clients own mission. Managing Director of Origin Packaging, Keith Wade explains the achievement; “Achieving the ISO 15378 certification further differentiates Origin Pharma Packaging and reinforces our position of leading Hybrid Packaging Partner. From design through to supply of primary packaging in the pharmaceutical industry, we continue to strengthen our processes to ensure they match pharmaceutical standards.  Eventually we are contributing to, improving and saving lives”.

Origin Packaging are experts in supply chain management and new product development (leading in child safety) for the pharmaceutical primary packaging market. Origin is based in Melton, UK - working strategically across Europe with major licence holders and contract manufacturing organisations.

ENDS

Contact:

Richard Quelch – Head of Marketing

Richard.quelch@originltd.com

01482 638380

http://www.originltd.com/

Notes for editor:

At Origin we produce pharmaceutical packaging and partner License holders and CMOs to improve the supply chain.

We add value by first understanding your ideals and then helping to achieve them.  We facilitate reduced inventory, support LEAN, increase speed to market and enable other outcomes not supported by the traditional supply chain.

We're based in the UK and provide a regional platform for Europe, which is our primary focus.  Our functions equate a hybrid of production, range and service and we supply associated products alongside our own major NPD department.  Flexing beyond our own product portfolio provides clients with access to a wider range, enables supplier consolidation, optimum supply chain performance and the enduring success of our relationship.

We’re an essential partner to companies faced with resource constraints – typical of all major pharma companies today.